For more than five years, a unique consortium ofÂ gynecologic oncologists in Georgia have been participating in the GynecologicÂ Oncology Group (GOG), anÂ international cooperative group that receives fundingÂ from the National Cancer Institute of the National Institutes for Health. The GOG studies gynecologic cancers through aÂ menu of clinical trials. Developed and administered byÂ Georgia CORE â€“ theÂ Center for Oncology, Research and Education â€“ the Georgia working group is a uniqueÂ statewide consortium recognized by NCI as a member of the GOG.
â€œGeorgia affiliates in the GOGÂ studies have exceeded the required participation goals by 200 percent,â€ saidÂ Sharad Ghamande, M.D., of Georgia Regents University and Principal InvestigatorÂ of the Georgia CORE GOG. â€œAndÂ perhaps more importantly, one quarter of theÂ patients who participated in the Georgia trials in the past three years are ofÂ racial and ethnic minorities â€“ historically the groups least likely to receiveÂ the benefits of clinical cancer research.â€
TheÂ GOG is administratively headquartered in Philadelphia, Pa. Approximately 45Â individual clinical trials are active at any one time within GOG for patientsÂ with a variety of gynecologic malignancies, including cancers thatÂ arise fromÂ the ovaries, uterus, cervix, vagina, and vulva.
In addition to conducting trials, Georgia COREÂ GOG Investigators serve on several national committees and have co-authoredÂ papers.
Georgia CORE GOG ConsortiumÂ affiliates include Central Georgia GynecologicÂ Oncology/The Medical Center of Central Georgia, Maconâ€¨; Emory University, Atlanta; â€¨Georgia Regents University,Â Augustaâ€¨; Columbus Regional HealthcareÂ System/John B. Amos Cancer Center, Columbus;â€¨ Memorial Health MedicalÂ Center, Savannah;â€¨ Northeast Georgia MedicalÂ Center, Gainesvilleâ€¨; Northside Hospital, Atlantaâ€¨; Piedmont Healthcare, Atlanta; and â€¨Lewis Cancer & ResearchÂ Pavilion at St. Josephâ€™s/Candler Health System, Savannah.